Open AccessMultidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component
Author(s) -
Erin M. Corsini,
Kyle G. Mitchell,
Eric Sceusi,
Reza J. Mehran,
David C. Rice,
Boris Sepesi,
Garrett L. Walsh,
Stephen G. Swisher,
Jack A. Roth,
Ara A. Vaporciyan,
Wayne L. Hofstetter,
Mara B. Antonoff
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.08.20
Subject(s) - medicine , radiation therapy , adjuvant therapy , disease , surgery , univariate analysis , stage (stratigraphy) , oncology , multivariate analysis , neuroendocrine tumors , cancer , survival analysis , neoadjuvant therapy , cohort , breast cancer , paleontology , biology
Thymic neuroendocrine tumors (NETs) are rare malignancies often treated in a multidisciplinary fashion. However, evidence for adjunctive therapy is limited, and predictors of survival and recurrence are not well established.